Given the absence of alternative evidence-based interventions for treatment-resistant schizophrenia, we suggest that rechallenging with clozapine should be considered in most patients with ...

In our experience, without the use of colony-stimulating factors in the aforementioned patients, we have noted the occurrence of moderate neutropenia, occasionally necessitating treatment delays.